Nanding, Zuilybeth S.
HRN: 18-60-81 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2022
CEFUROXIME 750MG (VIAL)
09/28/2022
10/06/2022
IVTT
390mg
Q8
UTI
Waiting Final Action